#DDDD 4D Pharma 📈

Good intro video on what should be THE Microbiome Unicorn stock

$200bn Merck $MRK own 7% of 4D
Merck signed $1bn+ vaccine licence deal with 4D
Merck's Keytruda in Phase I/II cancer trial alongside 4D LBT

+ potential COVID19 treatment in Clinical Trials https://t.co/D4v3nhhS3H